GB
Goodwin Biotechnology, Inc
SEC filingOther Health Care · Plantation, FL
Amount raised$2Msold at filing
Total offering$4M$2M still open
Investors in the raise2count reported to the SEC
FiledJan 27, 2026first sale Dec 5, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Karl PintoExecutive Officer, Director
Nikhil PuriDirector
Brandon PriceDirector
Kent PayneDirector
Divya MenezesDirector
Steven VorgityExecutive Officer
Executive officers, directors and promoters as listed on the Form D.